Search research articles
Contact Us
Filters
Showing results (141-150 of 210) with videos related to
Page
of 21
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology
|
April 25, 2003
The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells
Joanna M Day, Simon P Newman, Alexander Comninos, et al.
International Journal of Cancer
|
March 3, 2004
Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates
Simon P Newman, Mathew P Leese, Atul Purohit, et al.
Journal of Medicinal Chemistry
|
August 5, 2005
A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents
Mathew P Leese, Hatem A M Hejaz, Mary F Mahon, et al.
Diabetologia
|
November 28, 2019
Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data
Fay Crawford, Donald J Nicolson, Aparna E Amanna, et al.
Anticancer Research
|
September 27, 2015
The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression
Chloe Stengel, Simon P Newman, Mathew P Leese, et al.
International Journal of Clinical Practice
|
May 17, 2006
Stratification of foot ulcer risk in patients with diabetes: a population-based study
G P Leese, F Reid, V Green, et al.
Journal of Medicinal Chemistry
|
March 16, 2010
Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate
Fabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
ACS Medicinal Chemistry Letters
|
January 17, 2012
Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors
Mathew P Leese, Fabrice Jourdan, Wolfgang Dohle, et al.
European Thyroid Journal
|
December 24, 2021
Evidence of a Causal Relationship between Serum Thyroid-Stimulating Hormone and Osteoporotic Bone Fractures
Enrique Soto-Pedre, Moneeza K Siddiqui, Ify Mordi, et al.
Biochemical and Biophysical Research Communications
|
March 30, 2004
2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor
Julie E Reed, L W Lawrence Woo, James J Robinson, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 210) with videos related to
Sort By:
Page
of 21
The Journal of Steroid Biochemistry and Molecular Biology
|
April 25, 2003
The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells
Joanna M Day, Simon P Newman, Alexander Comninos, et al.
International Journal of Cancer
|
March 3, 2004
Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates
Simon P Newman, Mathew P Leese, Atul Purohit, et al.
Journal of Medicinal Chemistry
|
August 5, 2005
A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents
Mathew P Leese, Hatem A M Hejaz, Mary F Mahon, et al.
Diabetologia
|
November 28, 2019
Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data
Fay Crawford, Donald J Nicolson, Aparna E Amanna, et al.
Anticancer Research
|
September 27, 2015
The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression
Chloe Stengel, Simon P Newman, Mathew P Leese, et al.
International Journal of Clinical Practice
|
May 17, 2006
Stratification of foot ulcer risk in patients with diabetes: a population-based study
G P Leese, F Reid, V Green, et al.
Journal of Medicinal Chemistry
|
March 16, 2010
Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate
Fabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
ACS Medicinal Chemistry Letters
|
January 17, 2012
Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors
Mathew P Leese, Fabrice Jourdan, Wolfgang Dohle, et al.
European Thyroid Journal
|
December 24, 2021
Evidence of a Causal Relationship between Serum Thyroid-Stimulating Hormone and Osteoporotic Bone Fractures
Enrique Soto-Pedre, Moneeza K Siddiqui, Ify Mordi, et al.
Biochemical and Biophysical Research Communications
|
March 30, 2004
2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor
Julie E Reed, L W Lawrence Woo, James J Robinson, et al.
Page
of 21